JNJ - J&J transfers Ponvory FDA applications to Vanda launch seen in Q3
2024-05-30 17:57:18 ET
More on Vanda Pharmaceuticals
- Vanda Pharmaceuticals, Inc. (VNDA) Q1 2024 Earnings Call Transcript
- Vanda Pharmaceuticals: Fanapt Bipolar Win Doesn't Change Much
- Vanda Pharmaceuticals rejects sweetened bid from Future Pak
- Vanda reports positive Phase 3 data for motion sickness drug
- Seeking Alpha’s Quant Rating on Vanda Pharmaceuticals